{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:31:39Z","timestamp":1791909099325,"version":"4.3.4"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Cannabis use is prevalent among adolescents and young adults who vape nicotine. It is not known if cannabis use affects nicotine vaping cessation success.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess whether baseline frequency of cannabis use or cannabis use disorder (CUD) symptom severity was associated with nicotine vaping cessation in a randomized clinical trial.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This secondary analysis of a randomized clinical trial with youth who vaped nicotine recruited at a single site in Massachusetts from June 2022 to May 2024. The trial included 3 groups receiving 12 weeks of varenicline treatment and placebo (both double-masked, paired with counseling), as well as single-masked referral to texting-app\u2013based nicotine vaping cessation support (enhanced usual care [EUC]). Eligible participants were aged 16 to 25 years who reported vaping nicotine regularly and did not smoke tobacco.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Baseline cannabis use was assessed via self-reported number of days of cannabis use per week and with Cannabis Use Disorder Identification Test (CUDIT) scores.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Biochemically verified 7-day point prevalence nicotine vaping abstinence at week 12. Logistic regression models estimated associations between baseline cannabis use and vaping abstinence. Interaction terms were evaluated to examine whether cannabis use moderated the effect of varenicline on nicotine abstinence.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Among the 261 participants randomized to nicotine vaping cessation treatment (mean [SD] age, 21.5 [2.0] years; 139 female [53%]), 28% (73 participants) reported no past-month cannabis use, 38% (100 participants) reported using cannabis more than 0 and less than 4 d\/wk, and 30% (78 participants) reported using cannabis 4 to 7 d\/wk. Cannabis use frequency was not significantly associated with nicotine vaping cessation (eg, 4 to 7 d\/wk use vs no use: adjusted odds ratio [aOR], 1.14; 95% CI, 0.51-2.57; overall\n P<\/jats:italic>\n \u2009=\u2009.20). Nor did cannabis frequency modify the effect of varenicline (eg, abstinence varenicline vs placebo or EUC among those with 4 to 7 d\/wk use: aOR, 8.47; 95% CI, 2.78-28.25; vs among those with no use: aOR, 5.60; 95% CI, 1.97-17.06; overall interaction\n P<\/jats:italic>\n \u2009=\u2009.32). Findings were similar for CUD symptom severity.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Among adolescents and young adults attempting to reduce or stop nicotine vaping, baseline cannabis use was not associated with nicotine vaping abstinence. Varenicline proved helpful for nicotine vaping cessation regardless of cannabis use, indicating that co-use of cannabis may not represent a barrier to successful nicotine vaping cessation treatment.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT05367492<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.47799","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T16:30:29Z","timestamp":1765557029000},"page":"e2547799","source":"Crossref","is-referenced-by-count":5,"title":["Cannabis Use and Nicotine Vaping Cessation Outcomes"],"prefix":"10.1001","volume":"8","author":[{"given":"Jodi M.","family":"Gilman","sequence":"first","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Cather","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison T.","family":"Reeder","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Biostatistics Center, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryn","family":"Evohr","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys N.","family":"Pachas","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Gray","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin A.","family":"McClure","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi M.","family":"Schuster","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Eden","family":"Evins","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"issue":"5","key":"zoi251284r1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1001\/jama.2019.20185","article-title":"Trends in reported marijuana vaping among US adolescents, 2017\u20132019.","volume":"323","author":"Miech","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"zoi251284r2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.11336","article-title":"Characteristics of e-cigarette use behaviors among US youth, 2020.","volume":"4","author":"Wang","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi251284r3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-1832","article-title":"Trajectories of e-cigarette and conventional cigarette use among youth.","volume":"141","author":"Bold","year":"2018","journal-title":"Pediatrics"},{"issue":"21","key":"zoi251284r4","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1001\/jama.2025.3810","article-title":"Varenicline for youth nicotine vaping cessation: a randomized clinical trial.","volume":"333","author":"Evins","year":"2025","journal-title":"JAMA"},{"issue":"7","key":"zoi251284r5","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1360-0443.2012.03837.x","article-title":"The co-occurring use and misuse of cannabis and tobacco: a review.","volume":"107","author":"Agrawal","year":"2012","journal-title":"Addiction"},{"issue":"1-3","key":"zoi251284r6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.drugalcdep.2008.08.007","article-title":"Tobacco and cannabis co-occurrence: does route of administration matter?","volume":"99","author":"Agrawal","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"zoi251284r7","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1111\/add.15381","article-title":"Cannabis use and co-use in tobacco smokers and non-smokers: prevalence and associations with mental health in a cross-sectional, nationally representative sample of adults in Great Britain, 2020.","volume":"116","author":"Hindocha","year":"2021","journal-title":"Addiction"},{"issue":"2","key":"zoi251284r8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cpr.2011.12.002","article-title":"Tobacco and marijuana use among adolescents and young adults: a systematic review of their co-use.","volume":"32","author":"Ramo","year":"2012","journal-title":"Clin Psychol Rev"},{"key":"zoi251284r9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.addbeh.2015.05.012","article-title":"Assessing the overlap between tobacco and marijuana: trends in patterns of co-use of tobacco and marijuana in adults from 2003-2012.","volume":"49","author":"Schauer","year":"2015","journal-title":"Addict Behav"},{"key":"zoi251284r10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.drugalcdep.2017.12.007","article-title":"Correlates and trends in youth co-use of marijuana and tobacco in the United States, 2005-2014.","volume":"185","author":"Schauer","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi251284r11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2105\/AJPH.2017.304050","article-title":"Trends in daily cannabis use among cigarette smokers: United States, 2002-2014.","volume":"108","author":"Goodwin","year":"2018","journal-title":"Am J Public Health"},{"key":"zoi251284r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2024.108173","article-title":"Use of cannabis among youth who vape nicotine.","volume":"160","author":"Davis","year":"2025","journal-title":"Addict Behav"},{"issue":"1","key":"zoi251284r13","first-page":"30","article-title":"Exploring associations between the use of alcohol and marijuana with e-cigarette use in a USA nationally representative sample of young adults.","volume":"13","author":"Bluestein","year":"2019","journal-title":"Int J Health Sci (Qassim)"},{"issue":"6","key":"zoi251284r14","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/ntr\/ntaa265","article-title":"Young adults\u2019 vaping, readiness to quit, and recent quit attempts: the role of co-use with cigarettes and marijuana.","volume":"23","author":"Berg","year":"2021","journal-title":"Nicotine Tob Res"},{"issue":"6","key":"zoi251284r15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1080\/07448481.2019.1583662","article-title":"Comparing American college and noncollege young adults on e-cigarette use patterns including polysubstance use and reasons for using e-cigarettes.","volume":"68","author":"Buu","year":"2020","journal-title":"J Am Coll Health"},{"key":"zoi251284r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109278","article-title":"Age groups differences in the prevalence and popularity of individual tobacco product use in young adult and adult marijuana and tobacco co-users and tobacco-only users: findings from Wave 4 of the Population Assessment of Tobacco and Health study.","author":"Cohn","year":"2022","journal-title":"Drug Alcohol Dependence"},{"key":"zoi251284r17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fpsyt.2016.00104","article-title":"No smoke without tobacco: a global overview of cannabis and tobacco routes of administration and their association with intention to quit.","volume":"7","author":"Hindocha","year":"2016","journal-title":"Front Psychiatry"},{"issue":"12","key":"zoi251284r18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0166-2236(98)01283-1","article-title":"Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.","volume":"21","author":"Di Marzo","year":"1998","journal-title":"Trends Neurosci"},{"issue":"2","key":"zoi251284r19","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/sj.bjp.0704479","article-title":"Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.","volume":"135","author":"Valjent","year":"2002","journal-title":"Br J Pharmacol"},{"key":"zoi251284r20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fpsyt.2015.00041","article-title":"Role of the endogenous cannabinoid system in nicotine addiction: novel insights.","volume":"6","author":"Gamaleddin","year":"2015","journal-title":"Front Psychiatry"},{"issue":"13","key":"zoi251284r21","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1097\/00001756-200409150-00028","article-title":"Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences.","volume":"15","author":"Le Foll","year":"2004","journal-title":"Neuroreport"},{"issue":"6","key":"zoi251284r22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1375\/twin.13.6.550","article-title":"Externalizing behaviors and cigarette smoking as predictors for use of illicit drugs: a longitudinal study among Finnish adolescent twins.","volume":"13","author":"Korhonen","year":"2010","journal-title":"Twin Res Hum Genet"},{"issue":"12","key":"zoi251284r23","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1001\/jamapediatrics.2019.3553","article-title":"Efficacy and safety of varenicline for adolescent smoking cessation: a randomized clinical trial.","volume":"173","author":"Gray","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"8","key":"zoi251284r24","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/ntr\/ntz170","article-title":"Cannabis and alcohol co-use in a smoking cessation pharmacotherapy trial for adolescents and emerging adults.","volume":"22","author":"McClure","year":"2020","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"zoi251284r25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/ajad.12382","article-title":"Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial.","volume":"25","author":"Rabin","year":"2016","journal-title":"Am J Addict"},{"issue":"10","key":"zoi251284r26","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1158\/1055-9965.EPI-20-1810","article-title":"Association between smoking cannabis and quitting cigarettes in a large American Cancer Society cohort.","volume":"30","author":"Westmaas","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10037","key":"zoi251284r27","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"key":"zoi251284r28","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1083791","article-title":"A randomized controlled trial of varenicline and brief behavioral counseling delivered by lay counselors for adolescent vaping cessation: Study protocol.","volume":"14","author":"Schuster","year":"2023","journal-title":"Front Psychiatry"},{"issue":"9","key":"zoi251284r29","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/jama.2024.11057","article-title":"A vaping cessation text message program for adolescent e-cigarette users: a randomized clinical trial.","volume":"332","author":"Graham","year":"2024","journal-title":"JAMA"},{"issue":"2","key":"zoi251284r30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/ntr\/ntu204","article-title":"Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking E-cigarette users.","volume":"17","author":"Foulds","year":"2015","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"zoi251284r31","doi-asserted-by":"publisher","first-page":"168","DOI":"10.15288\/jsa.1995.56.168","article-title":"Comparison of three alcohol consumption measures: a concurrent validity study.","volume":"56","author":"Grant","year":"1995","journal-title":"J Stud Alcohol"},{"issue":"1-2","key":"zoi251284r32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.drugalcdep.2010.02.017","article-title":"An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R).","volume":"110","author":"Adamson","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"zoi251284r33","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II.","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"issue":"3","key":"zoi251284r34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1001\/jamapediatrics.2023.6263","article-title":"Substance use, suicidal thoughts, and psychiatric comorbidities among high school students.","volume":"178","author":"Tervo-Clemmens","year":"2024","journal-title":"JAMA Pediatr"},{"issue":"5","key":"zoi251284r35","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1037\/adb0000380","article-title":"Nonacute effects of cannabis use on motivation and reward sensitivity in humans: a systematic review.","volume":"32","author":"Pacheco-Col\u00f3n","year":"2018","journal-title":"Psychol Addict Behav"},{"issue":"11","key":"zoi251284r36","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1111\/acer.12854","article-title":"Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial.","volume":"39","author":"de Bejczy","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"issue":"2","key":"zoi251284r37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/JCP.0b013e3182870551","article-title":"Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.","volume":"33","author":"Meszaros","year":"2013","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"zoi251284r38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1001\/jamapsychiatry.2017.3544","article-title":"Effect of varenicline combined with medical management on alcohol use disorder with comorbid cigarette smoking: a randomized clinical trial.","volume":"75","author":"O\u2019Malley","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"zoi251284r39","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/adb.12664","article-title":"Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse.","volume":"24","author":"Herrmann","year":"2019","journal-title":"Addict Biol"},{"key":"zoi251284r40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109111","article-title":"Varenicline as a treatment for cannabis use disorder: a placebo-controlled pilot trial.","author":"McRae-Clark","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"zoi251284r41","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2024.108101","article-title":"Intention to quit or reduce e-cigarettes, cannabis, and their co-use among a school-based sample of adolescents.","volume":"157","author":"Liu","year":"2024","journal-title":"Addict Behav"},{"issue":"9","key":"zoi251284r42","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/jama.2024.13403","article-title":"Vaping in youth.","volume":"332","author":"Winickoff","year":"2024","journal-title":"JAMA"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2842688\/gilman_2025_oi_251284_1764969750.58769.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T16:30:30Z","timestamp":1765557030000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2842688"}},"subtitle":["A Secondary Analysis of a Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.47799","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]}}}